Vaccine trials: Bharat Biotech recruits 23,000 volunteers

Bharat Biotech has recruited 23,000 volunteers and continued to progress towards achieving the goal of 26,000 participants for Phase-3 clinical trial of its COVID-19 vaccine Covaxin across multiple......

Covaxin safe for children: Bharat Biotech

IMAGE: An Auxiliary Nurse Midwife healthcare worker inoculating a beneficiary with a dose of the COVID-19 vaccine during a door to door vaccination campaign at Margomunda, in Deoghar, Jharkhand,......

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......

Covaxin booster can neutralise Omicron, Delta variants: Bharat Biotech

Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on the Omicron and Delta variants of COVID-19. Image used for representational......

Bird flu: Bharat Biotech to develop vaccine

Close on the heels of Hetero Drugs launching Oseltamivir, an anti-bird flu drug, Nasdaq-listed Novavax Inc and Hyderabad-based Bharat Biotech International on Monday announced a strategic......

Bharat Biotech starts Covaxin's at-risk manufacture

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results, reports Sohini Das. Photograph: Kind courtesy Bharat Biotech  ......

What's behind Bharat Biotech's Zika 'hype'?

Bharat Biotech started work on developing a vaccine against Zika way back in 2014, but the timing of its announcement has created a flutter in the market. When Bharat Biotech recently......

Meet the man behind India's Genome Valley

This is the amazing story of Dr Krishna M Ella, a scientist who turned into a serial entrepreneur. Krishna Ella, chairman and managing director of Bharat Biotech International Ltd, is one of the......